Join our mailing list!
(Your shopping cart is empty)
Diane Publishing Books
Prescription Drugs: FDA Has Met Most Performance Goals for Reviewing Applications
Marcia G. Crosse (au)
The FDA is responsible for overseeing the safety and efficacy of drugs and biologics sold in the U.S. New drugs and biologics must be reviewed by FDA before they can be marketed. The FDA reviews new drug applications (NDA), biologic license applications (BLA), and efficacy supplements that propose changes to the way approved drugs and biologics are marketed or used. This report: (1) examines trends in FDAäó»s NDA and BLA review performance for FY 2000 through 2010; (2) examines trends in FDAäó»s efficacy supplement review performance for FYs 2000 through 2010; and (3) describes issues that have been raised about the drug and biologic review processes and steps FDA is taking that address them. A print on demand report.
Guide to Metal Toys
American Short Story, 1945-1980: A Critical History
American Vegetarian Resource Directory: Some Signposts on the Journey Towards a Healthier, More Ethically & Environmentally Balanced Lifestyle
Supporting the Sky
Suggestions of Abuse: True & False Memories of Childhood Sexual Trauma
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
Become an Affiliate
Send Us Feedback
Copyright ï¿½ 2004 Diane Publishing Company. All Rights Reserved.